Management of quinine toxicity.
The clinical findings, investigations, and course of three patients who ingested quinine sulphate or bisulphate tablets and suffered severe visual loss are described. Methods and control of treatment for these patients are discussed, and the assessment of the effectiveness of treatment, and its relationship to the visual outcome are considered.
D000328:Adult; D001766:Blindness / Q000139:chemically induced; D005260:Female; D005440:Fluid Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009755:Night Blindness / Q000139:chemically induced; D010530:Peritoneal Dialysis; D010956:Plasmapheresis; D011803:Quinine / Q000506:poisoning*; D006435:Renal Dialysis; D014786:Vision Disorders / Q000139:chemically induced* / Q000628:therapy; D014792:Visual Acuity
D011803:Quinine